Cerebrospinal fluid assay

作者: Johan Karl Olov Skog

DOI:

关键词: Cerebrospinal fluidBiomarkerPathologyMedicineNucleic acidMicrovesicles

摘要: The present invention is directed to methods of isolating particles, such as nucleic acid-containing particles or microvesicles, from a biological sample and extracting acids therefrom, wherein the cerebrospinal fluid. further provides for aiding diagnosis, prognosis, monitoring evaluation disease other medical condition in subject by detecting biomarker associated with thereof.

参考文章(59)
Stuart G. Fischer, Leonard S. Lerman, [11] Two-dimensional electrophoretic separation of restriction enzyme fragments of DNA Methods in Enzymology. ,vol. 68, pp. 183- 191 ,(1979) , 10.1016/0076-6879(79)68013-8
Linda Fay Pfizer Global Res. Dev. Nelms, Bernie Michael Pfizer Global Res. Dev. Silber, Walter Frost White, Lida Helen Pfizer Global Res. Dev. Kimmel, Bertrand Leo Pfizer Global Res. Dev. Chenard, Holly Daria Pfizer Global Res. Dev. Soares, David Lee Pfizer Global Res. Dev. Friedman, Method of monitoring neuroprotective treatment ,(2002)
Mikkel Noerholm, Xandra O. Breakefield, Bob Carter, Johan Karl Olov Skog, Use of microvesicles in analyzing nucleic acid profiles ,(2010)